115P UV1 vaccine with standard of care PD-1 checkpoint inhibitor as first-line treatment for non-small cell lung cancer (NSCLC): A randomized phase II trial
115P UV1 vaccine with standard of care PD-1 checkpoint inhibitor as first-line treatment for non-small cell lung cancer (NSCLC): A randomized phase II trial | Researchclopedia